Due to a simultaneous stimulation by IL-2 and TGF-β, and the expression of the high affinity IL-2 receptor, T cells are more likely to differentiate into CD4+ Treg cells that protect the tumor by consuming IL-2 and secreting IL-10 and TGF-β [50,51]. This evidence concerns the gene TGFB1 and neoplasm.